V Imaging News Today

Echo findings in heart failure patients with preserved or mildly reduced ejection fraction treated with an atrial shunt shed light on why only certain patients respond to therapy.

Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.

In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI.

In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.

Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.

Two classes of pervasive environmental chemicals that are present in household cleaners, furniture and electronics had "surprising" effects specifically on the non-nerve cells in the brain.

A new study pitted goal-setting strategies against peer-to-peer sharing and learning to see which would help older adults increase physical activity.

Heart rate and blood pressure rise when interventional cardiologists are performing PCI for coronary total occlusion compared with other work activities, a new study shows.

Two breakdown products from excess niacin, called 2PY and 4PY, were strongly associated with myocardial infarction, stroke, and other adverse cardiac events in multiple analyses.

Some patients with large vessel occlusion strokes may still benefit from thrombolysis even after the traditional 4.5-hour window, new analysis of the TIMELESS trial suggested.